Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study

NCT: NCT07515261 · COMPLETED

NCT IDNCT07515261
StatusCOMPLETED
Start Date2023-03-10
Completion2024-05-01

Brief Summary

This study will evaluate the feasibility and preliminary efficacy of pBFS-guided TMS treatment at DMPFC in autism spectrum disorder comorbid with language delay.

Frequently Asked Questions

What is pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study?

pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study is a clinical trial registered under NCT07515261. Current status: COMPLETED.

What is the status of NCT07515261?

The current status of NCT07515261 (pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study) is: COMPLETED.

When did pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study start?

pBFS Guided Neuromodulation Over DMPFC for ASD Treatment: Pilot Study started on 2023-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑